Nancy J. Hutson

Insider Reports History

Location
Stonington, CT
Signature
/s/ Alane P. Barnes, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy J. Hutson:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIOCRYST PHARMACEUTICALS INC Director Common Stock 99,138 $1,025,086 $10.34 12 Jun 2025 Direct
Endo International plc Director Ordinary Shares 116,140 $727,036 $6.26 11 Jun 2021 Direct
Clearside Biomedical, Inc. Director Common Stock 93,000 $118,110 $1.27 03 Oct 2023 Direct
Clearside Biomedical, Inc. Director Stock Option (right to buy) 45,000 20 Jun 2024 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 37,510 19 May 2023 Direct
BIOCRYST PHARMACEUTICALS INC Director Automatic Stock Option Grant 27,181 12 Jun 2025 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 4,000 19 May 2023 Held in an individual retirement account for the benefit of the Reporting Person
PhaseBio Pharmaceuticals Inc Director Restricted Stock Units 0 19 May 2023 Direct

Insider Reports Filed by Nancy J. Hutson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCRX BIOCRYST PHARMACEUTICALS INC 12 Jun 2025 2 $0 4 Director 16 Jun 2025, 16:20
BCRX BIOCRYST PHARMACEUTICALS INC 13 Dec 2024 1 -$52,780 4 Director 16 Dec 2024, 16:35
CLSD Clearside Biomedical, Inc. 20 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:15
BCRX BIOCRYST PHARMACEUTICALS INC 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 16:27
BCRX BIOCRYST PHARMACEUTICALS INC 20 May 2024 1 +$31,900 4 Director 22 May 2024, 07:24
CLSD Clearside Biomedical, Inc. 03 Oct 2023 1 +$8,600 4 Director 04 Oct 2023, 17:06
CLSD Clearside Biomedical, Inc. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:38
BCRX BIOCRYST PHARMACEUTICALS INC 13 Jun 2023 3 -$103,443 4 Director 15 Jun 2023, 16:33
/report/000116924523000027-hutson-nancy-j-2023-05-19 PhaseBio Pharmaceuticals Inc 19 May 2023 2 $0 4 Director 19 May 2023, 16:15
CLSD Clearside Biomedical, Inc. 17 Nov 2022 1 +$39,900 4 Director 21 Nov 2022, 07:12
CLSD Clearside Biomedical, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:25
BCRX BIOCRYST PHARMACEUTICALS INC 07 Jun 2022 2 $0 4 Director 09 Jun 2022, 16:48
/report/000116924522000064-hutson-nancy-j-2022-05-19 PhaseBio Pharmaceuticals Inc 19 May 2022 2 $0 4 Director 20 May 2022, 16:45
/report/000116924521000106-hutson-nancy-j-2021-11-05 PhaseBio Pharmaceuticals Inc 05 Nov 2021 6 $0 4 Director 08 Nov 2021, 17:26
CLSD Clearside Biomedical, Inc. 29 Oct 2021 4 +$81,350 4 Director 02 Nov 2021, 16:40
BCRX BIOCRYST PHARMACEUTICALS INC 15 Oct 2021 9 -$1,253,550 4 Director 19 Oct 2021, 16:21
/report/000116924522000067-hutson-nancy-j-2021-08-18-restatement PhaseBio Pharmaceuticals Inc 18 Aug 2021 1 +$9,240 4/A Director 20 May 2022, 16:47
CLSD Clearside Biomedical, Inc. 16 Aug 2021 1 +$17,040 4 Director 17 Aug 2021, 16:39
/report/000159303421000079-hutson-nancy-j-2021-06-11 Endo International plc 11 Jun 2021 2 -$143,999 4 Director 15 Jun 2021, 16:06
BCRX BIOCRYST PHARMACEUTICALS INC 10 Jun 2021 5 -$319,845 4 Director 14 Jun 2021, 16:29
CLSD Clearside Biomedical, Inc. 10 Jun 2021 1 $0 4 Director 11 Jun 2021, 17:40
/report/000116924521000060-hutson-nancy-j-2021-06-03 PhaseBio Pharmaceuticals Inc 03 Jun 2021 1 $0 4 Director 04 Jun 2021, 18:05
BCRX BIOCRYST PHARMACEUTICALS INC 28 May 2021 1 +$4,999 4 Director 01 Jun 2021, 16:24
BCRX BIOCRYST PHARMACEUTICALS INC 25 May 2021 1 $0 4 Director 27 May 2021, 16:24